AK Medical Holdings Limited disclosed a Next Day Disclosure Return confirming the repurchase of 50,000 ordinary shares on 17 September 2026 via on-market transactions at HKD 4.84 per share, for a total consideration of HKD 0.24 million.

Following the transaction, the company’s issued share capital (excluding treasury shares) declined by 0.0046% to 1.08 billion shares, while treasury shares rose to 32.49 million. Total issued shares remain unchanged at 1.11 billion.

The purchase was executed under the buyback mandate granted by shareholders on 17 June 2026, which authorises repurchases of up to 112.46 million shares. Including the latest transaction, AK Medical has repurchased 48.05 million shares, equivalent to 4.27% of the company’s issued share base at the time the mandate was approved. A moratorium restricts any new share issuance or sale of treasury shares until 17 October 2026.

Management confirmed that the buyback complied with Hong Kong Stock Exchange listing rules and all relevant regulatory requirements. The repurchased shares are being held as treasury stock.